S. Santus

Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification

M. Carta, G. Orrù, A. Scano, 2021, Pathogens.

Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection

F. Meloni, M. Carta, M. Campagna, 2021, PloS one.

Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience

F. Meloni, M. Carta, M. Campagna, 2020, Frontiers in Immunology.